Statistics for Relief Therapeutics Holding AG (id:13164 RLF)

Valuation metrics

Market cap

76.50M

Enterprise value

3.29M

Trailing P/E (ttm)

Forward P/E

PEG ratio

Price/Sales (ttm)

12.68

Price/Book (mrq)

1.46

Enterprise Value/Revenue

0.54

Enterprise Value/EBITDA

-0.19

Overview

Shares outstanding

12.54M

Float

9.56M

Shares short

% Held by insiders

0.01%

% Held by institutions

0.27%

Average volume (10 days)

149.61K

Average volume (90 days)

Price summary

52-Week low

1.06

52-Week high

7.60

52-Week change

64.34%

Beta

-14.74

50-Day moving average

4.40

200-Day moving average

2.07

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

May 05th, 2023

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

71.22%

Operating margin

-273.89%

Operational effectiveness

Return on assets

-9.35%

Return on equity

-99.35%

Income statement

Revenue (ttm)

0.51

Revenue per share (ttm)

0.51

Quarterly revenue growth (yoy)

Gross profit (ttm)

4.30M

EBITDA

-17,059,000.00

Net income to common (ttm)

-98,181,000.00

Diluted EPS (ttm)

-3.62

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

14.56M

Total cash per share (mrq)

1.16

Total debt (mrq)

4.31M

Total Debt/Equity (mrq)

8.25

Current ratio (mrq)

264.90%

Book value per share (mrq)

4.16

Cash flow

Cash flow statement

-17,612,000.00

Levered free cash flow (LFCF)

-4,025,875.00